SMTL ID : 9lfu.1 (1 other biounit)

Crystal structure of human RIP3 kinase domain complexed with LK01003

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.93 Å

Oligo State

monomer

Ligands

1 x 01: 2-cyclopentyl-~{N}-(6-propan-2-ylsulfonylquinolin-4-yl)-1,3-benzothiazol-5-amine

01.1: 19 residues within 4Å: Chain A: V.58, G.59, V.66, A.79, K.81, V.92, M.95, L.104, L.123, T.125, K.126, F.127, M.128, S.132, L.180, A.190, D.191, F.192, L.194 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.66, A:A.79, A:K.81, A:V.92, A:L.104, A:F.127, A:L.180, A:A.190, A:F.192, A:L.194 Hydrogen bonds: A:M.128, A:D.191 pi-Stacking: A:F.127 pi-Cation interactions: A:K.81

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Su, H. et al., Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro. Nat Commun (2025)

Release Date

2025-05-07

Peptides

Receptor-interacting serine/threonine-protein kinase 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Receptor-interacting serine/threonine-protein kinase 3

Related Entries With Identical Sequence